| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ani Pharmaceuticals, Inc. (ANIP) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. ANIP is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 431.9K | $34.33M | - | |
| CEO | 411.2K | $32.69M | - | |
| CFO | 230.9K | $18.35M | - | |
| VP | 158.5K | $12.60M | - | |
| Other | 91.3K | $7.26M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2023 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 36,190 | $53.00 | $1,918,079.91 | -1.2% | +9.5% | +10.4% | |
| Nov 15, 2023 | Davis Krista45 | SVP, Chief Hr Officer | Sell | 2,622 | $53.81 | $141,089.82 | -7.4% | +5.2% | +12.6% | |
| Nov 13, 2023 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 250 | $52.03 | $13,007.50 | -0.7% | +10.4% | +18.1% | |
| Nov 10, 2023 | Mutz Christopher | Head Of Rare Disease | Sell | 3,000 | $52.47 | $157,410.00 | -4.5% | +7.2% | +17.8% | |
| Oct 19, 2023 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 25,000 | $57.75 | $1,443,868.50 | -0.8% | -3.0% | +5.2% | |
| Oct 16, 2023 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 25,000 | $57.96 | $1,449,035.99 | -1.2% | -5.4% | +0.0% | |
| Oct 2, 2023 | Gassert Chad60 | SVP - Corp. Dev. &Strategy | Sell | 20,000 | $56.48 | $1,129,600.00 | -6.4% | +0.6% | +4.6% | |
| Sep 19, 2023 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 50,000 | $61.81 | $3,090,616.61 | -1.5% | -14.1% | -0.0% | |
| Sep 1, 2023 | Gassert Chad60 | SVP - Corp. Dev. &Strategy | Sell | 20,000 | $64.70 | $1,294,000.00 | -6.0% | -22.9% | -1.3% | |
| Aug 29, 2023 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 50,000 | $63.22 | $3,160,750.00 | -2.1% | -19.6% | -1.3% |